Edition:
United Kingdom

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

6.87USD
17 Sep 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.87
Open
$6.70
Day's High
$6.91
Day's Low
$6.59
Volume
21,559
Avg. Vol
9,129
52-wk High
$10.63
52-wk Low
$4.51

Latest Key Developments (Source: Significant Developments)

Chembio Diagnostics Q1 Loss Per Share $0.16 Including Items
Wednesday, 1 May 2019 

May 1 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 REVENUE $8.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $8.6 MILLION.Q1 LOSS PER SHARE $0.16 INCLUDING ITEMS.SEES FY 2019 REVENUE $36 MILLION TO $40 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $-0.15 -- REFINITIV IBES DATA.FY2019 REVENUE VIEW $38.1 MILLION -- REFINITIV IBES DATA.  Full Article

Chembio Diagnostics Announces Approval of Zika, Dengue and Chikungunya Point-of-Care Multiplex Test by Brazil’s Health Regulatory Agency
Tuesday, 9 Apr 2019 

April 9 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS INC - ANNOUNCES APPROVAL OF ZIKA, DENGUE AND CHIKUNGUNYA POINT-OF-CARE MULTIPLEX TEST BY BRAZIL'S HEALTH REGULATORY AGENCY.CHEMBIO DIAGNOSTICS INC - ANVISA APPROVAL ADVANCES CHEMBIO'S PREVIOUSLY ANNOUNCED COMMERCIAL AGREEMENT WITH BIO-MANGUINHOS.  Full Article

Chembio Diagnostics Reports Fourth Quarter And Full Year 2018 Financial Results
Thursday, 7 Mar 2019 

March 7 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.21.Q4 REVENUE $7.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $7.1 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $-0.17 -- REFINITIV IBES DATA.SEES FY 2019 REVENUE $36 MILLION TO $40 MILLION.INTRODUCED 5-YEAR TARGETS OF $100 MILLION IN REVENUE BY 2023 AND 50% GROSS MARGINS BY YEAR END 2023.  Full Article

Chembio Diagnostics Awarded Unicef Contract To Supply Point-Of-Care Zika/Chikungunya/Dengue Tests And Micro Readers
Thursday, 7 Mar 2019 

March 7 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS AWARDED UNICEF CONTRACT TO SUPPLY POINT-OF-CARE ZIKA/CHIKUNGUNYA/DENGUE TESTS AND MICRO READERS.CHEMBIO - UNICEF LTA, VALID THROUGH DEC 31, 2020, INCLUDES FIRM PURCHASE COMMITMENT OF $1.5 MILLION AND POSSIBLE ADDITIONAL PURCHASES OF UP TO $2.0 MILLION.  Full Article

FDA Authorizes Emergency Use Of First Ebola Fingerstick Test With Portable Reader To Chembio Diagnostic Systems
Friday, 9 Nov 2018 

Nov 9 (Reuters) - FDA::FDA AUTHORIZES EMERGENCY USE OF FIRST EBOLA FINGERSTICK TEST WITH PORTABLE READER.FDA SAYS ISSUANCE OF THE EUA FOR THE DPP EBOLA ANTIGEN SYSTEM IS TO CHEMBIO DIAGNOSTIC SYSTEMS INC.  Full Article

Chembio Diagnostics Announces Proposed Public Offering Of Common Stock
Wednesday, 31 Oct 2018 

Oct 31 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.CHEMBIO DIAGNOSTICS INC - INTENDS TO USE NET PROCEEDS FROM PROPOSED OFFERING TO FUND ITS PROPOSED ACQUISITION OF OPTRICON GMBH ANNOUNCED ON OCT 22.  Full Article

Chembio Determines Not To Proceed With Proposed Public Offering Of Common Stock
Thursday, 25 Oct 2018 

Oct 25 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DETERMINES NOT TO PROCEED WITH PROPOSED PUBLIC OFFERING OF COMMON STOCK.CHEMBIO DIAGNOSTICS - DETERMINED NOT TO PROCEED WITH PROPOSED PUBLIC OFFERING OF $25 MILLION OF ITS COMMON STOCK PREVIOUSLY ANNOUNCED ON OCT 22.CHEMBIO DIAGNOSTICS - DETERMINATION RESULTS FROM ASSESSMENT BY MANAGEMENT THAT CURRENT EQUITY MARKET CONDITIONS ARE "NOT CONDUCIVE FOR AN OFFERING".  Full Article

Chembio Diagnostics Announces Proposed Public Offering Of Common Stock
Monday, 22 Oct 2018 

Oct 22 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.CHEMBIO DIAGNOSTICS INC - COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $25 MILLION OF ITS COMMON STOCK TO BE SOLD BY COMPANY.CHEMBIO DIAGNOSTICS INC - TO USE PROCEEDS TO FUND PROPOSED ACQUISITION OF OPTRICON GMBH, SUPPORT ITS BUSINESS GROWTH STRATEGY.  Full Article

Chembio Diagnostics Files For Offering
Monday, 22 Oct 2018 

Oct 22 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS INC FILES FOR OFFERING SHARES OF CO'S COMMON STOCK HAVING AGGREGATE OFFERING PRICE OF $25 MILLION - SEC FILING.  Full Article

Chembio Reports Preliminary Third Quarter 2018 Revenue
Monday, 22 Oct 2018 

Oct 22 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO REPORTS PRELIMINARY THIRD QUARTER 2018 REVENUE.SEES Q3 2018 REVENUE $9.2 MILLION TO $9.4 MILLION.SEES Q3 2018 REVENUE UP 21.3 TO 23.9 PERCENT.SIGNED A DEFINITIVE AGREEMENT TO ACQUIRE OPTRICON GMBH.UNDER TERMS OF PURCHASE AGREEMENT, CHEMBIO WILL PAY $5.5 MILLION IN CASH.ANTICIPATE PRODUCTION OF DPP TESTS ON NEW LINE DURING Q4 OF 2018.  Full Article

Chembio Diagnostics Inc News

» More CEMI.OQ News

Earnings vs. Estimates

» More Financials